1,650
Views
8
CrossRef citations to date
0
Altmetric
Original Paper

Radiation Therapy Dose Delivery

, , , , , & show all
Pages 85-91 | Received 11 Nov 2002, Accepted 07 Jan 2003, Published online: 04 May 2011

References

  • International Commission of Radiation Units and Measure-ments (ICRU). Prescribing, recording and reporting photon beam therapy. Bethesda MD: 1999. Report No. 62.
  • Nordic Association of Clinical Physics (NACP). Specification of dose delivery in radiation therapy. Acta Oncol 1997; 36 (Suppl 10): 1–32.
  • Hall E. Radiobiology for the radiologist. 5th ed. Philadelphia: Lippincott. Williams and Wilkins, 2000:.
  • Ägren-Cronquist AK. Qualification of the response of hetero-geneous tumours and organized tissues to fractionated radio-therapy: Stockholm University. Thesis; 1995.
  • IAEA Technical Report Series No. 398. Absorbed dose determination in external beam radiotherapy: an international code of practice for dosimetry based on standards of absorbed dose to water. Vienna: International Energy Agency: 2000.
  • Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys 1997; 24: 103–10.
  • International Commission on Radiation Units and Measure-ments (ICRU). Dose and volume specification for reporting interstitial therapy. Bethesda MD: 1997. Report No. 58.
  • Gerbaulet A, Potter R. Mazemn J-J, et al. The GEC ESTRO Handbook of brachytherapy. Estro booklet; 2002.
  • International Commission of Radiation Units and Measure-ments (ICRU). Dose and volume specification for reporting intracavitary therapy in gynaecology. Bethesda MD: 1985. Report No. 38.
  • Visser A. Symonds P. Dose and volume specification for reporting gynaecological brachytherapy: time for a change. Radiother Oncol 2001; 58: 1–4.
  • Potter R. Van Limbergen E, Gerstner N. et al. Survey of the use of ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother (Nicol 2001; 58: 11–8.
  • Turesson I, Johansson K-A, Mattsson S. The potential of proton and light ion beams in radiotherapy. Acta Oncol 2003; 42: 107–14.
  • Intensity Modulated Radiation Therapy Collaborative Work-ing Group. Intensity-modulated radiotherapy: Current status and issues of interest. Int J Radiat Oncol Biol Phys 2001; 51: 880 914.
  • Ma CM. Mok E, Kapur A, et al. Clinical implementation of a Monte Carlo treatment planning system. Med Phys 1999; 26: 2133–43.
  • Turesson I. Carlsson J. Brahme A. Glimelius B, Zackrisson B. Stenerlow B and the Swedish Cancer Society Investigation Group. Biological response to radiation therapy. Acta Oncol 2003; 42: 92–106.
  • Dong L. McGary J. Bellezza D. et al. Whole-body dose from Peacock-based IMRT treatment. Int J Radiat Oncol Biol Phys 2000; 48(Suppl 1): 342.
  • Debus J, Engenhart-Cabillic R. Kraft G, et at. The role of high-LET radiotherapy compared to conformal photon radiother-apy in adenoid cystic carcinoma. Strahlenther Onkol 1999: 175(Suppl 2): 63–5.
  • Britten RA, Peters Li, Murray D. Biological factors influencing the RBE of neutrons: implications for their past. present and future use in radiotherapy. Radiat Res 2001; 156: 125–35.
  • Skarsgard LD. Radiobiology with heavy charged particles: a historical review. Phys Med 1998; I4\(Suppl 1): 1–19.
  • Forssell-Aronsson E, Kjellén E, Mattsson S. et at. and the Swedish Cancer Society Investigation Group. Medical imaging for improved tumour characterisation. delineation and treat-ment verification. Acta Oncol 2002; 41: 604–14.
  • Zackrisson B, Mattsson S. Kjellén E. Glimelius B. and the Swedish Cancer Society Investigation Group. Research and development of radiation therapy in clinical routines. Acta Oncol 2003; 42: 115–22.
  • GIimelius B, NordenskjOld B. Kjellén E, et al. and the Swedish Cancer Society Investigation Group. Interactions between chemotherapy, endocrine therapy and radiation. Acta Oncol 2002; 41: 635–8.
  • Hellman S. Technology, biology and traffic. Acta Oncol 2001; 40: 679–81.
  • Coleman CN. Radiation oncology—linking technology and biology in the treatment of cancer. Acta Oncol 2002; 41: 6–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.